SMAC (Social, Mobile, Analytics & Cloud) in Life Science Vertical What is SMAC?

SMAC is new terminology for a collaborative technology using

  • Social Media
  • Mobility
  • Analytics
  • Cloud

With strong development of smart phones during last 5 years, access to data from any where at any time is possible

  • Cloud Technology offer sharing of hardware & software resources is possible, without really investing
  • Facebook has developed concept of Social Media & new business model is developed, where decisions are based on Relationship & not only on Transactions
  • With expanding data availability, need for data analysis & suggest predictive right decision has become important.

In next 5 years this will bring big Business Process change by Adopting SMAC technology.
Today effective use of Information Technology has limited applications with large & mid size organisations.
SMAC will help Small organisations to adopt benefits of technology to achieve Business Excellence. This will improve productivity, performance & profitability. Small Businesses can grow in global business.

SMAC in Life Science

Social Media – Life Science vertical will improve relationship with Doctors & Patients. The Sales Force will share product details, dosage etc. Patients with similar treatment can share experience in a group. Company will be able to develop a brand.
The distributors, suppliers, contract manufacturers & other service providers like consultants etc can share their skills with better collaboration. This will develop better team for mutual benefits.

Mobile – Life Science business needs integration with mobile field force, connectivity with Doctors & Patients & integration of data across supply chain. Mobile will help in sharing the data across the network.
Right Information at Right Time will bring Right Decision to improve business operation

Analytics – It is observed that volume of data is doubling every six months, analyzing & presenting data for better decision-making is a challenge. Analytics will share right data at right time based on business rules user has defined. The alerts can be shared on mobile for quick decision/ corrective action.
Life Science Supply Chain has become very complex due to logistics, contract manufacturing, suppliers & regulatory documentation. These challenges are easily supported a well-designed analytics system.

Cloud – Cloud technology will compile all data generated at all locations & will share with all members based on access
© RESPA Inc Private & Confidential 3
Ajay Techma Systems Pvt Ltd ,
offered as per security defined. This reduces an investment in hardware & software. For SMBs investment & maintenance of such resources is a big challenge. SMBs can use these resources based on the requirements & pay on usage basis. SMBs can select the functionality of solutions, users & pay according to usage.
Life Science vertical are spread across many locations of distribution, manufacturing & contract manufacturing. To compile & correlate data centrally can be done effectively by Cloud technology.

SMAC in Life Science

Supply Chain Process Integration

Benefits from SMAC

SMAC/Cloud Technology can help all levels of an organisation:
– At infrastructure level, companies can get processing power, network bandwidth and storage from the outside on an on-demand basis.

– At platform level, cloud-based environments provide application developers with tools for development, testing, deployment, runtime libraries and hosting.

– At application level, clouds running on third-party infrastructure span all major enterprise solution areas, ranging from sales order, procurement to enterprise resource planning, content management.

– At business process Life Science industry level, cloud-based solutions (also known as business process utilities or platform-based business process outsourcing) offer Internet-enabled, externally provisioned services for managing business processes

SMAC/ SCM for Life Sciences solutions will support Business challenges & will help to achieve the following benefits:

  • Increased sales by 5-10%
  • Reduced cash-to-cash cycles by 20%
  • Reductions of 10-25% in WIP and finished goods inventories
  • Improvements of 10-20% in on-time deliveries
  • Reduced order cycle times by 10-25%
  • Increased labor productivity and reduced labor cost by 10-35%
  • Improvements in quality of 3-11%
  • Reduced expediting and freight expense by 5-30%
  • Improved asset utilization by 5-20%

Scope of improvements in pharma supply chain from Internet -Pharma Engg Magazine

Key performance indicators Average pharmaceutical industry Scope of improvement World class manufacturing plant
Stock turn
3 to 5
10 times
50% increase
300% increase
Cycle time (Hrs)
Decrease by 90 times

SMAC Challenges

Cloud still presents challenges, particularly for an industry in which data protection is of primary importance and intellectual property disputes are common.

Concerns remain about the security of data stored within the cloud and there is still a lack of clarity about the rights and responsibilities of cloud providers and users, although this is likely to change as the platform becomes more widely adopted.

SMAC CLOUD Market Potential

Gartner reports that Workday, Workforce Software, Cornerstone On Demand and NetSuite are the fastest-growing vendors worldwide from 2012 to 2013.
Workday’s revenue grew 86.1%,
WorkForce Software, 57.6%;
Cornerstone On Demand, 57%;
NetSuite, 39.6%.

Accenture to invest over $400m in Cloud technologies

Global technology and consultancy giant Accenture today said it will invest more than $ 400 million by 2015 in cloud technologies, capabilities and training.

According to research firm IDC, the total market size for cloud technologies is expected to grow to $98 billion in 2016 from about $40 billion in 2012.

Kleiner Perkins, Salesforce, Put $10.5M In Supply Chain Management Platform

Stealthy cloud startup Kenandy <> has raised $10.5 Million

Kenandy basically puts manufacturing management in the cloud. The startup which is led by Sandra Kurtzig (previous founder, CEO and chairman of the Ask Group), horizontally integrates all aspects of supply chain management for manufacturers including, inventory management, engineering, purchasing, and production. The company is also leveraging Salesforce’s cloud application management platform, allowing companies to manage mobile and social applications.

This solution is focused on Engineering vertical, so is not in our competition, we focus on Life Science/ Process Industry Forester predicts SaaS will account for 26% of the package software market by 2016

Why Investors and Boards are driving to Cloud- SaaS

Forward thinking investors and boards wanting to capitalize on the higher returns for SaaS companies are investing in new SaaS companies and moving their On-premises companies to pure SaaS or Hybrid on-premise/SaaS models. Justin Perreault of Commonwealth Capital Ventures say SaaS, along with developments in mobility and other corners of the cloud market are driving a renaissance in venture capital.

Venture Capitalists have shifted funding from on-premise software companies to SaaS, Big Data, and Mobile software.
Private Equity groups are seeing major opportunities to fund the traditional on-premises software companies’ move to a SaaS model and reap heightened valuations. Financial firms are getting comfortable monetizing the SaaS subscription revenue stream helping SaaS companies reduce their working capital requirements.

Investors are getting comfortable with SaaS business models

VC software investments have moved to SaaS companies.

SMAC for Life Science vertical focus solution, where there is increasing need for regulatory requirements, complexity of supply chain management & global competition.


Pharma Global Standards could reduce the need for redundant inventories across healthcare value chain. Today healthcare industry has half a trillion dollars tied up in inventory & better collaboration through could reduce obsolescence & inventory redundancy. Global standards could enable inventory reduction of $ 60-94 billion & reduce cost of managing & storing inventory by $10-14 billion. It could help reduce obsolescence by $19-27 billion.
End to end supply chain visibility could create new opportunities in mobile health, helping patients to maintain their regimes, avoid drug interactions & learn more about products & how to order refills electronically for delivery at home.
Pharmaceutical industry has just begun its journey to supply chain excellence. Consider few performance indicators

  • Average pharmaceutical manufacturer carries 7 months of inventory & the whole value chain down to patient hold about 9-10 months of inventory triple or quadruple the inventories of many consumers goods segment
  • Obsolescence costs the typical pharmaceutical manufacturer 3-4% of cost of goods although some see rates of up to 6-8%. Assuming additional obsolescence of 1-2% downstream pharmaceutical carry 4-6% of product cost in obsolesces.